Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorSingapore National Eye Centre
About this trial
The purpose of this research study is to understand the mechanism of action of low level light therapy and also potentially yield markers associated with good treatment response. Low-level light therapy is light-based treatment delivered through advance eye-light device. This therapy uses light energy to provide energy to the meibomian gland cells to slow down age-ing, improve tear stability and reduce inflammation.
Eligibility criteria
Qualifiers
Must be eligible for, and have consented for low level light therapy
Must not have presented to the clinic for an acute eye problem such as visual loss or painful eye
Ability to give informed consent.
Age more or equals to 21 years old.
Disqualifiers
Patients who are unable to or decline to give consent.
Age less than 21 years old.
Patients who presented to the clinic for an acute eye problem such as visual loss or painful eye.
Pregnant
Trial design
Treatments tested in this trial
- Not listed
Trial groups
30 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov